SAB Biotherapeutics Progressing on Therapeutic for COVID-19

Click Here To View


Executive Team

Eddie J. Sullivan, PhD
President & CEO

Eddie Hamilton, DVM
Executive Chairman BOD

Charles Randall, Jr.
Chief Financial Officer
Executive VP

Rick Finnegan
Chief Business Officer
Executive VP of Program Management

Melissa Ullerich 
Chief Communications Officer
Executive VP

Christoph Bausch, PhD
Chief Science Officer

Tom Luke, MD
Chief Medical Officer

Jerry Pommer, MSc, PAS, DACAWS
Chief Compliance Officer

Hua Wu, PhD
Senior VP, Vaccinology and Antibody Development


Executive Directors

Todd Stahl, MS
Animal Management

Kristi Egland, PhD
Molecular Genetics and Immunology

Board of Directors

Eddie Hamilton, DVM
Executive Chairman / Co-Founder
SAB Biotherapeutics

David Link
Vice Chairman
Retired Executive Vice President
Sanford Health

Eddie J. Sullivan, PhD
President, CEO & Co-Founder
SAB Biotherapeutics

Christine Hamilton
Managing Partner, Christiansen Land & Cattle
Co-Owner BioDak, LLC

Bill Polvino, MD
Bridge Medicines

Scientific Advisory Board

Jim Robl, PhD
Retired Biotechnology Executive & Professor

Scott A. Lesley, Ph.D.
Vice President, Discovery Biologics
Merck Research Laboratories

Arturo Casadevall, MD, PhD
Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases
Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine

Michael Haller, MD, MS–CI
Chief, Program Director, Pediatric Endocrinology and Professor
University of Florida Medical Center

Contact Us

2301 E 60th St N
Sioux Falls, SD 57104

245 First Street, Suite 1836
Cambridge, MA 02142